APHAIA
Live / Registered — Registered (as of 04 Nov 2025)
What this means for you
Registered since 04 Nov 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Nov 2031: the §71 affidavit of use).
Record
- Serial number
- 79387263
- Registration number
- 8006925
- Mark type
- Word mark
- Filed
- 07 Nov 2023
- Published for opposition
- 16 Sept 2025
- Registered
- 04 Nov 2025
- Next maintenance filing
- §71 affidavit of use, due by 04 Nov 2031 (grace period to 04 May 2032)
- Attorney of record
- David H. Siegel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, mental disorders and gastroenterological diseases; pharmaceutical preparations for the prevention of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, mental disorders and gastroenterological diseases; pharmaceutical preparations for the treatment of pre-diabetic conditions, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, non-alcoholic steatohepatitis, depression, motivational disorders, depressive moods and malabsorption disorders; pharmaceutical preparations for the prevention of pre-diabetic conditions, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, non-alcoholic steatohepatitis, depression, motivational disorders, depressive moods and malabsorption disorders; pharmaceutical preparations for improving mood and mental and physical wellbeing; food supplements and dietary preparations adapted for medical purposes for the treatment of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, psychic disorders and gastroenterological diseases; food supplements and dietary preparations adapted for medical purposes for the prevention of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, psychic disorders and gastroenterological diseases; food supplements and dietetic preparations adapted for medical purposes for the treatment of pre-diabetic states, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, depression, motivational disorders, depressed mood and malabsorption disorders; food supplements and dietetic preparations adapted for medical purposes for the prevention of pre-diabetic states, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, depression, motivational disorders, depressed mood and malabsorption disorders; food supplements and dietetic preparations adapted for medical purposes for improving mood and mental and physical well-being all of the foregoing excluding any goods that consist of, contain or are derived from cannabis, marijuana or hemp
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; biochemical research and development services; medical research and development services; all of the foregoing excluding services in relation to any goods that consist of, contain or are derived from cannabis, marijuana or hemp
Owner
- APHAIA PHARMA AG, CH
- APHAIA PHARMA AG, CH
- APHAIA IP AG, CH
- APHAIA IP AG, CH
Prosecution history
- 18 Jun 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 May 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 May 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 May 2026 — FINAL DISPOSITION PROCESSED
- 04 Feb 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 04 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 02 Oct 2025 — CHANGE OF OWNER RECEIVED FROM IB
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED